Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Aion Therapeutic’s Proprietary Mushroom Preparations Shown Effective in Killing Breast Cancer Cells

Aion Therapeutic’s Proprietary Mushroom Preparations Shown Effective in Killing Breast Cancer Cells

  • Post published:April 21, 2021
  • Post category:Press Release
Read more about the article Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers)

Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers)

  • Post published:March 11, 2021
  • Post category:Press Release
Read more about the article Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry in Jamaica; Hires Leading Psychiatrist as Medical Director

Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry in Jamaica; Hires Leading Psychiatrist as Medical Director

  • Post published:February 23, 2021
  • Post category:Press Release
Read more about the article Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

  • Post published:February 22, 2021
  • Post category:Press Release
Read more about the article Aion Therapeutic Grants Stock Options; Announces Management Change

Aion Therapeutic Grants Stock Options; Announces Management Change

  • Post published:February 4, 2021
  • Post category:Press Release
Read more about the article Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

  • Post published:December 23, 2020
  • Post category:Press Release
Read more about the article Aion Therapeutic Files Five Patents with the United States Patent and Trademark Office

Aion Therapeutic Files Five Patents with the United States Patent and Trademark Office

  • Post published:September 3, 2020
  • Post category:Press Release
Read more about the article Osoyoos Announces Name Change to “Aion Therapeutic Inc.”

Osoyoos Announces Name Change to “Aion Therapeutic Inc.”

  • Post published:August 27, 2020
  • Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More